Search results: Sage Journals

Open accessReview articleFirst published 2023

Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

Hagop M. Kantarjian, Aaron C. Logan, Faraz Zaman [...]

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2025

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

Jiangtao Li, Wenxuan Huo, Yang Yang [...]

Cell Transplantation

Free accessReview articleFirst published June, 2016

The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

Jonathan E. Benjamin, Anthony S. Stein

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published June, 2021

Characterization of relapse patterns in patients with acute lymphoblastic leukemia treated with blinatumomab

Kimberly M Lau, Ila M Saunders, Aaron M Goodman

Journal of Oncology Pharmacy Practice

Free accessReview articleFirst published October, 2015

CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)

Sarah K. Tasian, Rebecca A. Gardner

Therapeutic Advances in Hematology

Free accessReview articleFirst published January, 2024

Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19

Luna Acharya, Alpana Garg, Manoj Rai [...]

Journal of Investigative Medicine

Open accessReview articleFirst published December, 2018

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

J. Michael Savoy, Mary Alma Welch, Patrice E. Nasnas [...]

Therapeutic Advances in Hematology

Free accessReview articleFirst published October, 2015

The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia

Musa Yilmaz, Samantha Richard, Elias Jabbour

Therapeutic Advances in Hematology

Restricted accessReview articleFirst published September, 2015

Blinatumomab

Larry W. Buie, Joshua J. Pecoraro, Troy Z. Horvat [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published March, 2021

Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation,administration and toxicity challenges

Melanie B Bernhardt, Olga Militano, Lisa Honeyford [...]

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published 2023

Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

Hagop M. Kantarjian, Aaron C. Logan, Faraz Zaman [...]

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2025

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

Jiangtao Li, Wenxuan Huo, Yang Yang [...]

Cell Transplantation

Free accessReview articleFirst published June, 2016

The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

Jonathan E. Benjamin, Anthony S. Stein

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published June, 2021

Characterization of relapse patterns in patients with acute lymphoblastic leukemia treated with blinatumomab

Kimberly M Lau, Ila M Saunders, Aaron M Goodman

Journal of Oncology Pharmacy Practice

Free accessReview articleFirst published October, 2015

CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)

Sarah K. Tasian, Rebecca A. Gardner

Therapeutic Advances in Hematology

Free accessReview articleFirst published January, 2024

Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19

Luna Acharya, Alpana Garg, Manoj Rai [...]

Journal of Investigative Medicine

Open accessReview articleFirst published December, 2018

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

J. Michael Savoy, Mary Alma Welch, Patrice E. Nasnas [...]

Therapeutic Advances in Hematology

Free accessReview articleFirst published October, 2015

The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia

Musa Yilmaz, Samantha Richard, Elias Jabbour

Therapeutic Advances in Hematology

Restricted accessReview articleFirst published September, 2015

Blinatumomab

Larry W. Buie, Joshua J. Pecoraro, Troy Z. Horvat [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published March, 2021

Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation,administration and toxicity challenges

Melanie B Bernhardt, Olga Militano, Lisa Honeyford [...]

Journal of Oncology Pharmacy Practice